GlassScriptPhysician profile
Aminullah Amini
NPI 1922286517
$11,883.16
in general payments reported to CMS, 2019-2025
25 companies · $7,536 in 2025
The $7,536 reported for 2025 was more than what 83% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,329 · 2020: $371 · 2021: $601 · 2022: $700 · 2023: $628 · 2024: $718 · 2025: $7,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,600 · Food and Beverage: $3,253 · Travel and Lodging: $2,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,600.00 |
| Food and Beverage | $3,253.42 |
| Travel and Lodging | $2,028.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $5,582.05 | 2023-2025 | Excelsius Gps, Sable, Senza |
| Medtronic, INC. | $1,685.55 | 2022-2025 | Mazor X System, Unid_pass, Cd Horizon Spinal System |
| Boston Scientific Corporation | $1,390.09 | 2020-2025 | Wavewriter Alpha Prime 16, Infinion 16 |
| Medtronic USA, INC. | $1,127.85 | 2019-2020 | |
| Providence Medical Technology, INC. | $340.93 | 2019-2025 | |
| Cerapedics INC. | $283.44 | 2022 | |
| Abbott Laboratories | $227.35 | 2020-2021 | |
| Kuros Biosciences USA, INC | $202.70 | 2025 | Magnetos |
| Sunovion Pharmaceuticals INC. | $125.00 | 2019 | |
| Surgalign Spine Technologies, INC. | $121.75 | 2021 | |
| Orthofix Medical, INC. | $88.70 | 2019-2024 | Spinal-Stim, Cervical-Stim |
| Spine Wave, INC. | $88.03 | 2022-2025 | Spinal Implant, Testa Tp Pivoting Spacer System |
| Centinel Spine, LLC | $87.63 | 2024 | Prodisc C Vivo |
| Integra Lifesciences Corporation | $87.39 | 2019-2024 | Cusa Clarity, Codman Hakim, Codman Certas |
| Penumbra, INC. | $84.80 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $61.34 | 2023-2024 | Andexxa |
| Arbor Pharmaceuticals, INC. | $50.96 | 2019-2022 | |
| Biocomposites INC | $39.19 | 2019 | |
| Longeviti Neuro Solutions INC | $38.46 | 2025 | Clearfit |
| Arteriocyte Medical Systems, INC. | $36.69 | 2021-2022 | |
| Nevro Corp. | $32.19 | 2022 | |
| Livanova USA, INC. | $29.34 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Intrinsic Therapeutics | $28.56 | 2021-2023 | Barricaid Acd (Annular Closure Device) |
| Merck Sharp & Dohme LLC | $27.01 | 2024 | Welireg |
| Misonix INC | $16.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aminullah Amini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.